BDBM402061 2-cyclopropyl-N-{2-[(4,6- dimethylpyrimidin-2- yl)(methyl)amino]ethyl}-N-ethyl-6- methoxypyridine-3-carboxamide::US10011595, B-19

SMILES CCN(CCN(C)c1nc(C)cc(C)n1)C(=O)c1ccc(OC)nc1C1CC1

InChI Key InChIKey=VLLVBCCTOIMVGZ-UHFFFAOYSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 402061   

TargetOrexin receptor type 2(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM402061(US10011595, B-19 | 2-cyclopropyl-N-{2-[(4,6- dimet...)
Affinity DataIC50: 32.1nMAssay Description:In a typical experiment the OX1 and OX2 receptor antagonistic activity of the compounds of the present invention was determined in accordance with th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/26/2020
Entry Details
US Patent

TargetOrexin/Hypocretin receptor type 1(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM402061(US10011595, B-19 | 2-cyclopropyl-N-{2-[(4,6- dimet...)
Affinity DataIC50: 9.68E+3nMAssay Description:In a typical experiment the OX1 and OX2 receptor antagonistic activity of the compounds of the present invention was determined in accordance with th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/26/2020
Entry Details
US Patent